Patrick J. Gallagher

Smartmatic USA Corp., et al. v. Fox Corporation, et al. (N.Y.): Counsel for Fox Corporation and Fox News, and certain of its on-air commentators, in a defamation lawsuit concerning Fox’s coverage of the 2020 Presidential Election.

Strategic Investment Opportunities LLC v. Lee Enterprises, Inc. (Del. Ch.): Counsel for Lee Enterprises and its board of directors in an expedited bench trial. Won complete verdict upholding Lee’s enforcement of its advance notice bylaw amid a hostile M&A bid by hedge fund Alden Global Capital. Won subsequent expedited matter defeating Alden’s request to enjoin Lee’s annual shareholder meeting.

Trial counsel for a hedge fund in a one-week AAA arbitration. Won favorable verdict.

In re Opana ER Antitrust Litigation (N.D. Ill.): Trial counsel for Impax Laboratories in a multidistrict class action litigation alleging an anticompetitive reverse payment arising out of a patent litigation settlement concerning the opioid pain medication Opana ER®.

Compagnie des Grands Hotels d'Afrique S.A. v. Starwood Capital Group Global I LLC, et al. (D. Del.): Counsel for Starwood Capital Group and certain affiliates in litigation seeking to enforce a foreign arbitration award pursuant to an alter ego theory of liability.

State of West Virginia v. Pfizer, Inc. et al. (W. Va.): Counsel for Sun Pharma and its subsidiary, Ranbaxy, in a litigation alleging an anticompetitive reverse payment arising out of a patent litigation settlement concerning the cholesterol medication Lipitor®.

In re Zetia (Ezetimibe) Antitrust Litigation (E.D. Va.): Counsel for Glenmark Pharmaceuticals in a multidistrict class action litigation alleging an anticompetitive reverse payment arising out of a patent litigation settlement concerning the cholesterol medication Zetia®.

Value Drug Co., et al. v. Takeda Pharmaceuticals U.S.A., Inc., et al. (E.D. Pa.): Counsel for Teva and Amneal Pharmaceuticals in a litigation alleging an anticompetitive conspiracy arising out of patent litigation settlements concerning the gout medication Colcrys®.

In re Ranbaxy Generic Drug Application Antitrust Litigation (D. Mass.): Counsel for Sun Pharma and its subsidiary, Ranbaxy, in a multidistrict class action litigation alleging fraudulent misrepresentations to the FDA and antitrust violations.